Bryan Smith, associate professor of biomedical engineering at MSU, and a team of scientists created a “Trojan Horse” nanoparticle that can be directed to eat debris, reducing and stabilizing plaque. The discovery could be a potential treatment for atherosclerosis, a leading cause of death in the United States.
The results, published in the current issue of Nature Nanotechnology, showcases the nanoparticle that homes in on atherosclerotic plaque due to its high selectivity to a particular immune cell type – monocytes and macrophages. Once inside the macrophages in those plaques, it delivers a drug agent that stimulates the cell to engulf and eat cellular debris. Basically, it removes the diseased/dead cells in the plaque core. By reinvigorating the macrophages, plaque size is reduced and stabilized.
Smith said that future clinical trials on the nanoparticle are expected to reduce the risk of most types of heart attacks, with minimal side effects due to the unprecedented selectivity of the nanodrug.
Smith’s studies focus on intercepting the signaling of the receptors in the macrophages and sending a message via small molecules using nano-immunotherapeutic platforms. Previous studies have acted on the surface of the cells, but this new approach works intracellularly and has been effective in stimulating macrophages.
“We found we could stimulate the macrophages to selectively eat dead and dying cells – these inflammatory cells are precursor cells to atherosclerosis – that are part of the cause of heart attacks,” Smith said. “We could deliver a small molecule inside the macrophages to tell them to begin eating again.”
This approach also has applications beyond atherosclerosis, he added.
“We were able to marry a groundbreaking finding in atherosclerosis by our collaborators with the state-of-the-art selectivity and delivery capabilities of our advanced nanomaterial platform. We demonstrated the nanomaterials were able to selectively seek out and deliver a message to the very cells needed,” Smith said. “It gives a particular energy to our future work, which will include clinical translation of these nanomaterials using large animal models and human tissue tests. We believe it is better than previous methods.”
Smith has filed a provisional patent and will begin marketing it later this year.
A link to the original paper: https://www.nature.com/articles/s41565-019-0619-3
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Trojan Horse nanoparticle
- Health Watch: Researchers use ‘Trojan horse’ nanoparticles to fight artery plaqueon February 4, 2020 at 1:01 pm
which demonstrates the potential of ‘Trojan horse’ nanoparticles to prevent atherosclerotic cardiovascular disease.” White blood cells that took in the nanotubes went to inflammatory sites such as ...
- Trojan Horse Nanoparticle Eats Plaques That Cause Heart Attackson February 3, 2020 at 1:35 pm
In collaborative research published in Nature Nanotechnology, a team from the Universities of Stanford and Michigan State have developed a nanoparticle that is able to eat heart attack causing plaques ...
- Wild new ‘Trojan horse’ nanoparticle clears your arteries by gobbling up plaqueon January 30, 2020 at 1:06 pm
Developed by scientists at Michigan State and Stanford universities, the innovative new “Trojan Horse” nanoparticle works by munching away portions of the plaques responsible for heart attacks.
- Nanoparticle Trojan horse approach to clearing atherosclerotic plaqueson January 29, 2020 at 3:37 pm
which demonstrates the potential of ‘Trojan horse’ nanoparticles to prevent atherosclerotic cardiovascular disease.” As of now Professor Smith has filed for a patent for their nano molecules ...
- Nanoparticle eats away at plaque in arterieson January 28, 2020 at 7:19 am
A new “Trojan Horse” nanoparticle can eat away portions of the plaques that cause heart attacks, research in mice indicates. The discovery could be a potential treatment for atherosclerosis ...
Go deeper with Google Headlines on:
Trojan Horse nanoparticle
Go deeper with Bing News on:
- Atherosclerosis Drugs Market Latest In-Depth Report Segment by Manufacturers, Type, Applications and Dynamicson February 27, 2020 at 4:22 am
A recent report provides crucial insights along with application based and forecast information in the Global Atherosclerosis Drugs Market. The report provides a comprehensive analysis of key factors ...
- Restaurateur Harry Morton's Official Cause of Death Revealed by Los Angeles Coroner's Officeon February 26, 2020 at 4:23 pm
The 38-year-old died naturally from a probable cardiac arrhythmia and myocardial bridging with coronary artery atherosclerosis, the coroner’s office said. Harry, who had been training for a marathon, ...
- Pink Taco founder Harry Morton’s cause of death revealedon February 26, 2020 at 2:40 pm
Morton, who died suddenly at his Beverly Hills home last November, suffered “cardiac arrhythmia due to myocardial bridging with coronary artery atherosclerosis,” the coroner ruled in a final autopsy ...
- Boosting arginine metabolism to regress atherosclerosis?on February 26, 2020 at 1:20 pm
Efferocytosis, the process by which macrophages clear apoptotic cells, is a key part of resolving inflammation and maintaining tissue homeostasis. In atherosclerosis, efferocytosis is impaired, which ...
- Development of a two-stage limb ischemia model to better simulate human peripheral artery diseaseon February 26, 2020 at 2:31 am
Peripheral arterial disease (PAD) leads to impaired lower limb blood supply usually as a result of atherosclerosis and associated thrombosis 1. In 2010 an estimated 200 million people worldwide were ...